Derek Hainy

Derek Hainy

Healthcare Regulation Expert
Derek Hainy is a public policy expert specializing in healthcare regulation. He provides insightful analysis of the latest regulatory changes affecting healthcare providers. Focusing on compliance, Derek helps medical professionals navigate healthcare laws, requirements, and reforms. He also covers the future of healthcare data privacy regulations and the regulatory landscape for telehealth services. 
Ohio Medicaid Oversight Dissolved in Late-Night Move
Public Policy Ohio Medicaid Oversight Dissolved in Late-Night Move

Imagine a healthcare system so vast that it serves millions of vulnerable residents with a budget nearing $32 billion annually, yet in a single, shadowy decision, the very mechanism ensuring its accountability vanishes overnight. This is the reality facing Ohio's Medicaid program, one of the

Healthcare Accelerators Revolutionize Care Delivery
Public Policy Healthcare Accelerators Revolutionize Care Delivery

In a world where healthcare systems face mounting pressures from skyrocketing costs, an aging demographic, and persistent inequities in access to quality care, a transformative force is emerging to address these challenges head-on. Healthcare accelerators have become pivotal in reshaping how

How Will Liberty Robotic System Transform Vascular Surgery?
Public Policy How Will Liberty Robotic System Transform Vascular Surgery?

The Current Landscape of Vascular Surgery and Endovascular Robotics Vascular surgery, particularly peripheral endovascular procedures, stands as a cornerstone of modern healthcare, addressing critical conditions like arterial blockages and aneurysms that affect millions annually. These minimally

Hospital Industry Pushes for Urgent Funding Extensions
Public Policy Hospital Industry Pushes for Urgent Funding Extensions

Overview of the Hospital Industry and Current Financial Pressures The hospital industry stands as a vital pillar of the healthcare system, delivering essential medical services to millions of Americans daily while navigating an increasingly complex financial landscape. Hospitals, ranging from

Why Did FDA Reject Saol’s Rare Disease Drug for PDCD?
Public Policy Why Did FDA Reject Saol’s Rare Disease Drug for PDCD?

Understanding PDCD and the Rare Disease Landscape Imagine a world where a child’s life hinges on a treatment that exists but remains out of reach due to regulatory hurdles, a harsh reality for those affected by Pyruvate Dehydrogenase Complex Deficiency (PDCD). This ultra-rare pediatric m

How Can the SOAR Act Transform Lives with Oxygen Needs?
Public Policy How Can the SOAR Act Transform Lives with Oxygen Needs?

In a quiet suburban neighborhood, an elderly woman sits by her window, watching children play outside while a heavy oxygen tank anchors her to the living room, a scene that reflects the daily reality for millions of Americans with chronic respiratory conditions. For these individuals, a

RS Pondok Indah Group Achieves Stage 7 EMRAM in Indonesia
Public Policy RS Pondok Indah Group Achieves Stage 7 EMRAM in Indonesia

The Significance of Digital Transformation in Indonesian Healthcare In a nation where healthcare access and quality remain pressing challenges for millions, the rapid adoption of digital solutions is reshaping the landscape of medical services in Indonesia. With a population exceeding 270 million,

Florida Group Pushes Medicaid Expansion for 2026 Ballot
Public Policy Florida Group Pushes Medicaid Expansion for 2026 Ballot

I'm thrilled to sit down with Faisal Zain, a renowned healthcare expert with a deep background in medical technology and innovation. With years of experience in the manufacturing of medical devices for diagnostics and treatment, Faisal brings a unique perspective to the pressing issue of

How Will Colorado's New Healthcare Rules Impact Providers?
Public Policy How Will Colorado's New Healthcare Rules Impact Providers?

In the heart of Colorado's bustling healthcare sector, a seismic shift is underway as new regulations reshape the operational landscape for providers across the state, affecting over 2,000 licensed entities. With hospitals, nursing facilities, and home care agencies grappling with evolving

FDA's New Accelerated Pathway: Risks and Rewards for Pharma
Public Policy FDA's New Accelerated Pathway: Risks and Rewards for Pharma

Imagine a world where life-saving drugs reach patients in mere months rather than years, addressing urgent medical crises with unprecedented speed, and transforming the landscape of healthcare delivery. This vision is becoming a reality through the U.S. Food and Drug Administration's latest

Loading
Latest Articles

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later